Boiron SA - Strategy, SWOT and Corporate Finance Report
Summary
Boiron SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Boiron SA (Boiron or 'the company') manufactures, markets and distributes homeopathic medicines. The company’s product portfolio includes Camilia, Arnigel, Sedatif PC, Oscillococcinum, HomeovoX, Coryzalia, Homeoptic, Stodaline, Arnicalme, and Stodal. These medicines are used for the treatment of influenza symptoms such as headaches, fever, coughs, teething problems in nursing babies, anxiety and emotional disorders, minor sleep disorders, cold symptoms, and rhinitis. The products are also used for treating both adults and children suffering with ocular discomfort and irritation and for treatment of vocal disorders. Boiron offer these products in the form of tablets, syrups, single-dose liquids and ointments. The company is headquartered in Messimy, France
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook